Maserati could be a stand-alone brand in the future if it can become sustainably profitable, Stellantis Chief Financial Officer Richard Palmer said, adding that no decision has been made.
In recent years, a number of Maserati’s high-end competitors have been spun off from their parent companies as separate listings, including Ferrari (from Fiat) at the end of 2015 and Porsche (from Volkswagen Group) at the end of September. Aston Martin went public in 2018.
VW Group has also asked several of its separate brands to model what they would look like as public companies. Other recent market debuts include Geely and Volvo’s Polestar brand.
But the record is mixed for these new entrants. As of Thursday, Ferrari’s market capitalization nearly equalled that of Stellantis; Porsche’s share price has largely held value despite a larger market selloff. Aston Martin and Polestar, however, have struggled.
Maserati’s performance as part of Fiat Chrysler Automobiles ahead of the merger with PSA Group that created Stellantis was uneven, with ever-shifting product plans and sales forecasts that failed to pan out.
The brand has fared better under Stellantis, which was formed at the end of January 2021. Global sales rose by 41 percent in 2021 to 24,300 units.
Maserati revenue was up 47 percent in 2021 to more than 2 billion euros. Adjusted operating profit was 103 million euros compared with a loss of 91 million euros in 2020. Operating margin was 5.1 percent – and 6.5 percent in the second half after the MC20 supercar entered the market.
Third quarter revenues this year were up 23 percent this year over 2021, Stellantis announced Thursday. Shipments rose by 14 percent.
Palmer credited the launch of the Grecale midsize SUV, as well as higher sales of the MC20, for those gains. He said Maserati was well positioned to break what one analyst called the “boom and bust” cycle of previous years.
“I’m pretty confident we can break that pattern with the new team and product plan we have,” he told analysts Thursday on Stellantis’ third-quarter earnings call. “The frequency of launches is a big focus. In the past that has been our biggest issue, because we would launch a vehicle and leave an extended gap to the next one.”
“The important thing is to maintain enough novelty value in the lineup and continue to refresh it,” he added.
Asked whether Stellantis was planning to list Maserati separately, Palmer said the answer is “no” at the moment, as the group focused on building out the luxury brand’s product plan, which emphasizes a shift to full-electric models in the coming years.
“I am very optimistic and confident that we can build a very interesting luxury car business, and eventually at some point in time that could be an asset that can stand on its own,” he said. “Clearly it has a very strong brand, its own network and a very independent type of business, even in the way we run it inside Stellantis.”
Following the Grecale, Maserati will launch its most expensive model, the MC 20 Cielo, a roadster version of the sports car that will cost 260,000 euros. It will be followed by the lightweight GranTurismo coupe, on a new platform, as a serious competitor to Ferrari.
The GranTurismo will use the new Nettuno V-6 engine also found in the MC20 rather than the V-8 used in previous models.
It will be followed by the Gran Cabrio convertible, as well as a full-electric Folgore variant that tops the Porsche Taycan in acceleration.
By 2025, Maserati will launch full-electric versions of the MC20, as well as a new generation of the Quattroporte sports sedan and Levante large SUV, both as electric-only cars.
The Ghibli midsize sedan will not be replaced because of changing customer tastes, Maserati said earlier this year.
ivermectin 3mg oral – tegretol ca order carbamazepine 200mg
buy amoxil online cheap – buy diovan 80mg pill combivent 100mcg us
buy generic isotretinoin 40mg – buy zyvox pill how to buy zyvox
lasix order – buy generic betnovate online3 generic betnovate 20 gm
buy gabapentin medication – clomipramine 25mg drug itraconazole 100 mg oral
doxycycline price – purchase acticlate sale glucotrol 5mg uk
buy clavulanate pill – nizoral buy online cymbalta 20mg ca
order semaglutide 14 mg for sale – order levitra generic cyproheptadine generic
sildenafil 50mg cheap – viagra 50mg oral tadalafil 5mg without prescription
order cenforce generic – oral cenforce glucophage 500mg us
atorvastatin 80mg ca – order lisinopril 5mg order prinivil generic
lipitor 40mg tablet – zestril 5mg ca lisinopril 5mg usa
prilosec canada – metoprolol online buy order tenormin pills
buy medrol without prescription – triamcinolone 4mg without prescription order triamcinolone 4mg generic
buy desloratadine without a prescription – desloratadine 5mg price priligy tablet
cytotec price – buy diltiazem generic buy cheap diltiazem
acyclovir online buy – how to buy crestor crestor 20mg for sale
motilium online order – buy motilium pills for sale buy cyclobenzaprine pills
buy generic domperidone over the counter – buy motilium tablets buy cyclobenzaprine sale
inderal 10mg for sale – purchase methotrexate online order methotrexate for sale
buy generic medex – warfarin cheap cozaar 50mg pills
order levaquin 250mg generic – order ranitidine 300mg sale zantac generic
oral esomeprazole 20mg – imitrex online buy buy imitrex generic
mobic ca – buy tamsulosin pills for sale buy flomax online